DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Market Access (2688)

Tulsa | Oklahoma | 2019 | Market Overview (Event Driven)

Tulsa | Oklahoma | 2019 | Market Overview (Event Driven)

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

Tulsa's major health systems and physician groups are stregthening access to care across the region with the expansion of facilities and services. Physician groups also are participating in payment reform efforts driven by the Centers for Medicare and Medicaid services, increasing care coordination in the market. Pressure to contain costs under value-based models could promote greater adherence to drug regimens, which bodes well for pharma. However, Oklahoma’s new Medicaid drug pricing initiative, which enables the Oklahoma Health Care Authortiy to enter into outcomes-based contracts with drug makers, could give the state more leverage over pharmaceutical manufacturers.

  • Pub Date: February 2019

Purchase Report

Recent reports:
You may also be interested in: